Analysed PURETECH HEALTH PLC (PTCHF:OTCMKTS) News Sources
PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)
22-04-2026
yahoo.com
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
27-04-2026
yahoo.com
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
29-04-2026
yahoo.com
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
01-05-2026
proactiveinvestors.com
PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference
13-05-2026
yahoo.com
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
09-06-2026
yahoo.com
What is the current price of PURETECH HEALTH PLC (PTCHF:OTCMKTS)?
The current price of PURETECH HEALTH PLC (PTCHF:OTCMKTS) is $1.7.
PURETECH HEALTH PLC (PTCHF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of PURETECH HEALTH PLC (PTCHF:OTCMKTS) since the previous trading day is $-0.162.
PURETECH HEALTH PLC (PTCHF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of PURETECH HEALTH PLC (PTCHF:OTCMKTS) since the previous trading day is -8.7003%.
What is the most recent average sentiment score for PURETECH HEALTH PLC (PTCHF:OTCMKTS)?
The most recent average sentiment score for PURETECH HEALTH PLC (PTCHF:OTCMKTS) is 86 out of 100.
What is the most recent average sentiment for PURETECH HEALTH PLC (PTCHF:OTCMKTS)?
The most recent sentiment for PURETECH HEALTH PLC (PTCHF:OTCMKTS) is .
SEC-8K** Filing Available For PURETECH HEALTH PLC (PTCHF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.